Digestive Diseases and Sciences

, Volume 58, Issue 6, pp 1710–1716 | Cite as

Endoscopic Submucosal Dissection for Treatment of Gastric Submucosal Tumors Originating from the Muscularis Propria Layer

  • Shuo Zhang
  • Guan-Qun Chao
  • Men Li
  • Gui-Bao Ni
  • Bin LvEmail author
Original Article


Background and Aims

We aimed to study the feasibility of endoscopic submucosal dissection (ESD) for the removal of gastric muscularis propria tumors and to evaluate the efficacy and safety of ESD for this treatment.


Eighteen patients with gastric SMTs originating from the muscularis propria were treated by ESD between July 2008 and July 2011. Tumor characteristics, complications, en bloc resection rate, and local recurrence rate were evaluated.


Among the 18 patients, 11 were women (61.1 %). The median age was 65.3 ± 6.3 years old (range 30–71 years old). Seventeen tumors were resected completely by ESD (success rate 94.4 %). The mean tumor size as determined by endoscopic ultrasound was 2.6 ± 1.2 cm (range 1.0–3.5 cm). The histological diagnosis was gastrointestinal stromal tumor for 13 lesions and leiomyoma for four tumors. The mean operation time was 90 ± 38 min (range 50–120 min), and the average blood loss was 20 ml. Two patients developed perforation, which was closed by endoscopic methods with metallic clips. The tumor was closely adhered to the muscularis propria and was convex to the enterocoelia in one case. No single case had severe complications, such as GI bleeding, peritonitis, or abdominal abscess, and there were no other immediate post-procedure complications.


ESD is a safe, effective, well-tolerated, and minimally invasive therapy for the intraluminal SMTs originating from gastric muscularis propria with relatively few complications. Although there is a risk of perforation which has become manageable endoscopically.


Endoscopic submucosal dissection (ESD) Submucosal tumor (SMT) Therapeutic upper gastrointestinal endoscopy 


Conflict of interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.


  1. 1.
    Byrne MF, Jowell PS. Gastrointestinal imaging: endoscopic ultrasound. Gastroenterology. 2002;122:1631–1648.PubMedCrossRefGoogle Scholar
  2. 2.
    Eisen GM, Chutkan R, Goldstein JL, et al. Role of endoscopic ultrasonography. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc. 2000;52:852–859.Google Scholar
  3. 3.
    Hedenbro JL, Ekelund M, Wetterberg P. Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy. Surg Endosc. 1991;5:20–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Polkowski M. Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors. Endoscopy. 2005;37:635–645.PubMedCrossRefGoogle Scholar
  5. 5.
    Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–229.PubMedCrossRefGoogle Scholar
  6. 6.
    Ohkuwa M, Hosokawa K, Boku N, et al. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy. 2001;33:216–221.CrossRefGoogle Scholar
  7. 7.
    Minami S, Gotoda T, Ono H, Oda I, Hamanaka H. Complete endoscopic closure of gastric perforation induced by endoscopic resection of early gastric cancer using endoclips can prevent surgery (with video). Gastrointest Endosc. 2006;63:596–601.PubMedCrossRefGoogle Scholar
  8. 8.
    Heinrich H, Bauerfeind P. Endoscopic mucosal resection for staging and therapy of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:85–91.PubMedCrossRefGoogle Scholar
  9. 9.
    Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. In: Kleihues P, Sobin LH, eds. World Health Organization Classification of Tumours. Lyon: IARC Press; 2000.Google Scholar
  10. 10.
    Oda I, Saito D, Tada M, et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer. 2006;9:262–270.PubMedCrossRefGoogle Scholar
  11. 11.
    DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–58.PubMedCrossRefGoogle Scholar
  12. 12.
    Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol. 2002;3:655–664.PubMedCrossRefGoogle Scholar
  13. 13.
    Shiu MH, Farr GH, Papachristou DN, Hajdu SI. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer. 1982;49:177–187.PubMedCrossRefGoogle Scholar
  14. 14.
    Park YM, Cho E, Kang HY, Kim JM. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc. 2011;25:2666–2677. Epub. 03/18/2011.Google Scholar
  15. 15.
    Lee IL, Lin PY, Tung SY, Shen CH, Wei KL, Wu CS. Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer. Endoscopy. 2006;38:1024–1028.PubMedCrossRefGoogle Scholar
  16. 16.
    Kojima T, Takahashi H, Parra-Blanco A, et al. Diagnosis of submucosal tumor of the upper GI tract by endoscopic resection. Gastrointest Endosc. 1999;50:516–522.PubMedCrossRefGoogle Scholar
  17. 17.
    Arima S, Sakata Y, Ogata S, et al. Evaluation of hemostasis with soft coagulation using endoscopic hemostatic forceps in comparison with metallic hemoclips for bleeding gastric ulcers: a prospective, randomized trial. J Gastroenterol. 2010;45:501–505.PubMedCrossRefGoogle Scholar
  18. 18.
    Kawano S, Okada H, Kawahara Y, et al. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial. Digestion. 2011;84:46–53.PubMedCrossRefGoogle Scholar
  19. 19.
    Fujiwara S, Morita Y, Toyonaga T, et al. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. J Gastroenterol. 2011;46:595–602.PubMedCrossRefGoogle Scholar
  20. 20.
    Mori H, Rafiq K, Kobara H, et al. Local steroid injection into the artificial ulcer created by endoscopic submucosal dissection for gastric cancer: prevention of gastric deformity. Endoscopy. 2012;44:641–648.PubMedCrossRefGoogle Scholar
  21. 21.
    Grotz TE, Donohue JH. Surveillance strategies for gastrointestinal stromal tumors. J Surg Oncol. 2011;104:921–927.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Shuo Zhang
    • 1
  • Guan-Qun Chao
    • 2
  • Men Li
    • 1
  • Gui-Bao Ni
    • 3
  • Bin Lv
    • 1
    Email author
  1. 1.Department of Gastroenterology, The First Affiliated HospitalZhejiang Chinese Medical UniversityHangzhouChina
  2. 2.Department of Family Medicine, Sir Run Run Shaw HospitalZhejiang UniversityHangzhouChina
  3. 3.Department of Pathology, The First Affiliated HospitalZhejiang Chinese Medical UniversityHangzhouChina

Personalised recommendations